Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Camerini, Andrea
ALNEO, NCT05015010 / 2020-003432-25: Alectinib in Neo-adjuvant Treatment of Stage III NSCLC	Active, not recruiting	2	33	Europe	Alectinib	Gruppo Oncologico Italiano di Ricerca Clinica	Non Small Cell Lung Cancer	12/24	12/26
CAPLAND, NCT04811001 / 2019-002869-35: Best EGFR-TKI Sequence in NSCLC Harboring EGFR Mutations	Recruiting	2	170	Europe	Osimertinib, Tagrisso, Dacomitinib, Vizimpro	Fondazione Ricerca Traslazionale, Pfizer srl	NSCLC	12/23	12/23